Hi all,
Here are some studies showing insulin-sensitizers work for thin ladies with PCOS (including one that says they help even if we're not IR). I've included a quote from the findings, along with a link to the full study. Also, I included the one I posted the other day so that these are all in one place for future reference. I'll add more when I come across them. Feel free to do the same!
Let's go out there and educate those out-of-date docs!
Take care
Lissa
1- Insulin-sensitizing Medications Aid Polycystic Ovary Syndrome, Even Without Insulin Resistance, Obesity
“Treatment with insulin-sensitizing medications such as metformin (Glucophage®) promotes ovulation and reduces testosterone levels in women with polycystic ovary syndrome (PCOS), even if they are relatively lean and insulin-responsive.”
http://www.docguide.com/news/content...Other&count=10
2 - Lean Women with Polycystic Ovary Syndrome Respond to Insulin Reduction with Decreases in Ovarian P450c17 Activity and Serum Androgens
“Weight loss is first-line therapy for obese women with PCOS, but is not a therapeutic option for nonobese women with the disorder. The clinical importance of our findings is that they suggest that even normal weight and thin women with PCOS should respond to pharmacological measures to improve insulin sensitivity, such as administration of agents like metformin, with decreases in ovarian androgen production and serum androgens.”
http://jcem.endojournals.org/cgi/con...ull/82/12/4075
3 - Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.
“Menstrual cyclicity was restored in all amenorrheic and oligomenorrheic women. . .Metformin administration improves reproductive axis functioning in hyperandrogenic nonobese PCOS patients. By acting on the ovary and restoring normal ovarian activity, metformin positively modulates the reproductive axis (namely GnRH-LH episodic release).”
http://www.docguide.com/news/content...256DFC00808470
4 - Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
"In the metformin group of nonobese patients, the mean fasting serum insulin concentration decreased. . . Also in the metformin group of nonobese patients, the mean basal serum total testosterone, free testosterone, and androstenedione concentrations decreased by 38%, 58%, and 30%, respectively. In the obese patients treated with metformin, only free testosterone showed a statistically significant decrease."
http://www.docguide.com/news/content...256DFC00808470






Reply With Quote
Georgia
